[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-001", "question": "A 58-year-old man with a history of hypertrophic cardiomyopathy presents with recurrent syncope. Genetic testing reveals a mutation in the MYH7 gene. Echocardiography shows asymmetric septal hypertrophy with a left ventricular outflow tract gradient of 80 mmHg at rest. Despite optimal medical therapy with beta-blockers, he continues to experience symptoms. What is the most appropriate next step in management?", "options": ["Implantable cardioverter-defibrillator placement", "Septal myectomy", "Alcohol septal ablation", "Dual-chamber pacing", "Mavacamten initiation"], "answer": "E", "answer_index": 4, "explanation": "Mavacamten is the most appropriate next step as it is a cardiac myosin inhibitor specifically indicated for symptomatic obstructive hypertrophic cardiomyopathy refractory to beta-blockers, targeting the underlying pathophysiology. Septal myectomy and alcohol septal ablation are invasive options reserved for cases not responding to medical therapy, but mavacamten offers a non-invasive alternative with recent evidence supporting its use before procedural interventions. Implantable cardioverter-defibrillator and dual-chamber pacing address arrhythmic risks but not the outflow obstruction directly.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has hypertrophic cardiomyopathy with a significant resting LVOT gradient and recurrent syncope despite optimal beta-blocker therapy.  \nIn symptomatic patients with drug-refractory obstructive HCM and a significant gradient, septal reduction therapy is indicated.  \nSeptal myectomy (surgical) is the gold standard, especially when expertise is available, and is preferred over alcohol septal ablation in this case given the patient’s relatively young age (58) and significant resting gradient.  \nImplantable cardioverter-defibrillator placement is for primary or secondary prevention of sudden cardiac death but does not treat outflow obstruction or symptoms directly.  \nDual-chamber pacing is less effective for gradient reduction and is generally reserved for patients who are not candidates for septal reduction.  \nMavacamten is a newer medical option but is typically used before proceeding to invasive septal reduction in eligible patients; here, the patient is already refractory to optimal medical therapy.  \n\nThe answer is B"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-002", "question": "A 72-year-old woman with Parkinson's disease develops sudden onset of severe headache, vomiting, and left-sided hemiparesis. MRI reveals a right thalamic hemorrhage with intraventricular extension. She is on carbidopa-levodopa and has a history of orthostatic hypotension. What is the most likely underlying mechanism contributing to this event?", "options": ["Cerebral amyloid angiopathy", "Hypertensive vasculopathy", "Levodopa-induced vasospasm", "Orthostatic hypotension-related watershed infarction", "Dopaminergic therapy-associated coagulopathy"], "answer": "B", "answer_index": 1, "explanation": "Hypertensive vasculopathy is the most likely mechanism, as chronic hypertension in elderly patients with Parkinson's often leads to small vessel disease and thalamic hemorrhages. Cerebral amyloid angiopathy typically affects cortical regions, not deep structures like the thalamus. Levodopa does not directly cause vasospasm or coagulopathy, and while orthostatic hypotension is common, it more often results in ischemic rather than hemorrhagic events.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has Parkinson’s disease with orthostatic hypotension and presents with a thalamic hemorrhage.  \nThalamic hemorrhages are most commonly due to hypertensive vasculopathy affecting small deep perforating arteries (like thalamogeniculate arteries).  \nWhile Parkinson’s patients can have orthostatic hypotension (often from autonomic dysfunction or medications), this typically relates to syncope or watershed infarcts, not spontaneous deep brain hemorrhage.  \nThe acute hemorrhage here, given age and location, is most consistent with chronic hypertension causing lipohyalinosis and microaneurysm rupture, even if not noted in the vignette—it’s the most common mechanism for thalamic hemorrhage.  \n\nCerebral amyloid angiopathy (A) typically causes lobar hemorrhages in elderly, not deep thalamic bleeds.  \nLevodopa-induced vasospasm (C) is not a recognized cause of hemorrhage.  \nOrthostatic hypotension-related watershed infarction (D) would cause ischemic stroke, not hemorrhage.  \nDopaminergic therapy-associated coagulopathy (E) is not a known typical complication.  \n\nThus, hypertensive vasculopathy is the most likely underlying mechanism.  \n\n**The answer is B**"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-003", "question": "A 45-year-old man with type 1 diabetes mellitus presents with recurrent hypoglycemia despite dose adjustments. He has a history of autoimmune thyroiditis and vitiligo. Laboratory evaluation shows low morning cortisol and elevated ACTH. What is the most appropriate confirmatory test for the suspected diagnosis?", "options": ["Cosyntropin stimulation test", "Insulin tolerance test", "21-Hydroxylase antibody assay", "Adrenal CT scan", "Metyrapone test"], "answer": "C", "answer_index": 2, "explanation": "21-Hydroxylase antibody assay is the most appropriate confirmatory test for autoimmune adrenalitis in the context of polyglandular autoimmune syndrome type 2, given the patient's other autoimmune conditions. Cosyntropin stimulation test assesses adrenal reserve but does not confirm etiology. Insulin tolerance and metyrapone tests evaluate the hypothalamic-pituitary-adrenal axis but are less specific for autoimmune causes, and adrenal CT is imaging that may show atrophy but not confirm autoimmunity.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has type 1 diabetes, autoimmune thyroiditis, and vitiligo, suggesting autoimmune polyglandular syndrome type 2.  \nLow morning cortisol with elevated ACTH indicates primary adrenal insufficiency (Addison’s disease).  \nIn autoimmune adrenalitis, the most specific confirmatory test is detection of 21-hydroxylase antibodies.  \nWhile the cosyntropin stimulation test confirms adrenal insufficiency, the question asks for the most appropriate confirmatory test *for the suspected diagnosis* — here, the autoimmune cause.  \n\nThe answer is C.  \n\nThe answer is (C)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-004", "question": "A 60-year-old smoker with COPD presents with progressive dyspnea and hemoptysis. CT chest reveals a 2 cm spiculated nodule in the right upper lobe with mediastinal lymphadenopathy. Bronchoscopy with biopsy confirms squamous cell carcinoma. PET-CT shows no distant metastases. What is the most appropriate initial management?", "options": ["Stereotactic body radiotherapy", "Surgical lobectomy with lymph node dissection", "Concurrent chemoradiotherapy", "Immune checkpoint inhibitor monotherapy", "Epidermal growth factor receptor tyrosine kinase inhibitor"], "answer": "B", "answer_index": 1, "explanation": "Surgical lobectomy with lymph node dissection is the most appropriate for stage I squamous cell lung cancer in a patient with adequate pulmonary reserve, offering the best chance for cure. Stereotactic body radiotherapy is an alternative for non-surgical candidates, but this patient has no contraindications mentioned. Chemoradiotherapy and targeted therapies are for more advanced stages or specific molecular profiles not indicated here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has a biopsy-proven squamous cell carcinoma of the lung, clinically staged as T1c N2 M0 (Stage IIIA) given the 2 cm primary tumor and mediastinal lymphadenopathy with no distant metastases on PET-CT.  \n\nFor Stage IIIA non-small cell lung cancer (NSCLC) without distant metastases, and with N2 disease confirmed, the standard of care for a medically operable patient is concurrent chemoradiotherapy, often followed by consolidation immunotherapy. Surgical resection may be considered in select cases after neoadjuvant therapy, but upfront surgery is not the standard initial management for known N2 involvement.  \n\nGiven the options, the most appropriate initial management is concurrent chemoradiotherapy.  \n\nThe answer is C"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-005", "question": "A 35-year-old woman in the emergency department presents with chest pain, palpitations, and diaphoresis after using cocaine. ECG shows ST-segment elevation in leads V2-V4. Troponin is elevated. Coronary angiography reveals a thrombus in the left anterior descending artery with no underlying atherosclerosis. What is the most appropriate immediate management?", "options": ["Intracoronary thrombolysis", "Percutaneous coronary intervention with stenting", "Systemic anticoagulation with heparin", "Glycoprotein IIb/IIIa inhibitor infusion", "Aspiration thrombectomy"], "answer": "E", "answer_index": 4, "explanation": "Aspiration thrombectomy is the most appropriate for cocaine-induced myocardial infarction due to vasospasm and thrombus without atherosclerosis, allowing removal of the clot while minimizing vessel trauma. Stenting is unnecessary without plaque, and thrombolysis carries bleeding risks. Anticoagulation and glycoprotein inhibitors are adjunctive but not primary interventions for isolated thrombus.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": null, "model_outputs": "The patient has cocaine-induced acute coronary syndrome with"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-006", "question": "A 68-year-old man with atrial fibrillation on anticoagulation develops acute right-sided weakness. CT head shows no hemorrhage, and MRI confirms acute ischemic stroke in the left middle cerebral artery territory. He is within 4.5 hours of symptom onset. What is the most critical factor determining eligibility for intravenous thrombolysis?", "options": ["International normalized ratio value", "Time since last anticoagulant dose", "Presence of atrial fibrillation", "Stroke severity on NIHSS scale", "Reversal agent availability"], "answer": "A", "answer_index": 0, "explanation": "The international normalized ratio value is the most critical, as thrombolysis is contraindicated if INR >1.7 in patients on vitamin K antagonists to avoid hemorrhagic complications. Time since last dose affects coagulopathy but INR directly measures it. Atrial fibrillation and stroke severity influence overall management but not thrombolysis eligibility directly, and reversal agents are for bleeding, not pre-thrombolysis.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The most critical factor determining eligibility for intravenous thrombolysis in this patient on anticoagulation is the **time since last anticoagulant dose**, because it directly affects the current level of anticoagulation and bleeding risk.  \n\nWhile INR is important for warfarin, many patients are on direct oral anticoagulants (DOACs), and timing since the last dose is a key consideration in guidelines for thrombolysis eligibility in anticoagulated patients.  \n\nThe answer is B"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-007", "question": "A 52-year-old woman with acromegaly undergoes transsphenoidal surgery. Postoperatively, she develops polyuria with urine output exceeding 300 mL/hour. Serum sodium is 148 mEq/L, and urine specific gravity is 1.002. What is the most appropriate initial pharmacologic intervention?", "options": ["Desmopressin acetate", "Hydrochlorothiazide", "Demeclocycline", "Tolvaptan", "Conivaptan"], "answer": "A", "answer_index": 0, "explanation": "Desmopressin acetate is the most appropriate for central diabetes insipidus following pituitary surgery, replacing deficient antidiuretic hormone to concentrate urine. Hydrochlorothiazide is used for nephrogenic diabetes insipidus, not central. Demeclocycline and vasopressin antagonists like tolvaptan or conivaptan are for syndrome of inappropriate antidiuretic hormone, which would worsen hypernatremia here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has acromegaly and underwent transsphenoidal surgery, now presenting with high urine output (>300 mL/hour), hypernatremia (148 mEq/L), and dilute urine (specific gravity 1.002). This is consistent with central diabetes insipidus (DI) due to disruption of the posterior pituitary or hypothalamic-pituitary stalk during surgery.  \n\nThe most appropriate initial pharmacologic intervention for central DI is desmopressin acetate, a synthetic vasopressin analog that replaces ADH.  \n\nOther options:  \n- Hydrochlorothiazide: used in nephrogenic DI, not first-line for acute postoperative central DI.  \n- Demeclocycline: induces nephrogenic DI (used for SIADH).  \n- Tolvaptan: V2 receptor antagonist used for hyponatremia in SIADH, would worsen this condition.  \n- Conivaptan: V1a/V2 receptor antagonist for hyponatremia, also inappropriate here.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-008", "question": "A 55-year-old man with idiopathic pulmonary fibrosis presents with acute worsening dyspnea. High-resolution CT shows new ground-glass opacities superimposed on fibrosis. Bronchoalveolar lavage reveals neutrophilia without infection. What is the most appropriate therapeutic approach?", "options": ["High-dose systemic corticosteroids", "Azathioprine addition to regimen", "Pirfenidone dose escalation", "Nintedanib initiation", "Lung transplantation evaluation"], "answer": "A", "answer_index": 0, "explanation": "High-dose systemic corticosteroids are the most appropriate for acute exacerbation of idiopathic pulmonary fibrosis, aiming to suppress inflammation despite limited evidence. Azathioprine is contraindicated due to increased mortality risk. Pirfenidone and nintedanib are antifibrotics for stable disease, not acute flares, and transplantation is for end-stage but not immediate management.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The scenario describes an acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF), characterized by acute worsening of dyspnea, new ground-glass opacities on HRCT, and neutrophilia on BAL without infection.  \nThe standard initial management for AE-IPF is high-dose systemic corticosteroids, often with additional immunosuppressive therapy, despite limited evidence.  \n\nAmong the options:  \n- **A** matches the acute management step.  \n- **B** (azathioprine) is sometimes used in chronic IPF management but not as the immediate therapy for an acute exacerbation.  \n- **C** and **D** are antifibrotic maintenance therapies, not for acute exacerbations.  \n- **E** (lung transplant evaluation) is important in progressive disease but not the immediate therapeutic intervention for an acute exacerbation.  \n\nThe most appropriate initial therapeutic approach here is high-dose systemic corticosteroids.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-009", "question": "A 28-year-old man in the emergency department after a motor vehicle collision has hypotension, tachycardia, and abdominal distension. FAST exam shows free fluid in the abdomen. He is taken to the operating room for exploratory laparotomy, revealing a splenic laceration. What is the most appropriate intraoperative management for a hemodynamically unstable patient?", "options": ["Splenic artery embolization", "Partial splenectomy", "Splenorrhaphy with hemostatic agents", "Total splenectomy", "Non-operative management with observation"], "answer": "D", "answer_index": 3, "explanation": "Total splenectomy is the most appropriate for hemodynamically unstable patients with high-grade splenic injury to rapidly control bleeding and stabilize the patient. Embolization and non-operative management are for stable patients. Partial splenectomy or splenorrhaphy preserve splenic function but are time-consuming and risky in instability.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "In a hemodynamically unstable patient with a splenic injury found during exploratory laparotomy, the priority is rapid control of bleeding.  \nNon-operative management, partial splenectomy, or splenorrhaphy are typically reserved for stable patients or less severe injuries.  \nSplenic artery embolization is generally an adjunct or used in stable patients with contrast blush on CT.  \nFor unstable patients in the OR with significant bleeding, total splenectomy is the most reliable and rapid method to achieve hemostasis.  \n\nThe answer is D"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-010", "question": "A 65-year-old woman with rheumatoid arthritis develops shortness of breath. Echocardiography reveals severe mitral regurgitation with a flail leaflet. She has preserved left ventricular function but elevated pulmonary pressures. Coronary angiography is normal. What is the most appropriate intervention?", "options": ["Mitral valve repair", "Mitral valve replacement with bioprosthesis", "Transcatheter edge-to-edge repair", "Medical management with afterload reduction", "Cardiac resynchronization therapy"], "answer": "A", "answer_index": 0, "explanation": "Mitral valve repair is the most appropriate for severe primary mitral regurgitation due to flail leaflet in a surgical candidate, offering better durability and preservation of ventricular function compared to replacement. Transcatheter repair is for high-risk patients or functional regurgitation. Medical management and resynchronization do not address the structural defect.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has severe mitral regurgitation due to a flail leaflet with preserved left ventricular function and secondary pulmonary hypertension, which is a class I indication for surgical intervention.  \nIn the absence of significant calcification or rheumatic deformity, mitral valve repair is preferred over replacement when feasible because it preserves left ventricular function and avoids prosthetic valve complications.  \nGiven her normal coronary arteries and preserved LV function, repair is likely achievable and is the most appropriate intervention.  \n\nThe answer is A"}]